Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
6.17
+0.04 (0.65%)
At close: Jun 27, 2025, 4:00 PM
5.75
-0.42 (-6.81%)
After-hours: Jun 27, 2025, 8:00 PM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $61.50 million as of June 27, 2025. Its market cap has decreased by -25.03% in one year.
Market Cap
61.50M
Enterprise Value
57.64M
1-Year Change
-25.03%
Ranking
Category
Stock Price
6.17
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $61.50M, a decrease of -50.85%. That is a compound annual growth rate of -43.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 61.50M | 30.70% |
| Dec 31, 2024 | 47.05M | -62.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.70B |
| Johnson & Johnson | 364.42B |
| AbbVie | 330.79B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 275.27B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.09B |
| AstraZeneca | 215.99B |